STATEMENT ON THE RELEASE OF THE USG POLICY FOR OVERSIGHT OF DUAL USE RESEARCH OF CONCERN AND PATHOGENS WITH ENHANCED PANDEMIC POTENTIAL

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



U.S. Department of Health and Human Services

NATIONAL INSTITUTES OF HEALTH NIH News

NIH Office of the Director (OD) <https://www.nih.gov/institutes-nih/nih-office-director>

For Immediate Release: May 7, 2024

 

STATEMENT ON THE RELEASE OF THE USG POLICY FOR OVERSIGHT OF DUAL USE RESEARCH OF CONCERN AND PATHOGENS WITH ENHANCED PANDEMIC POTENTIAL

 

NIH has long championed robust oversight to responsibly fuel knowledge in support of improving human health. As such, I applaud the White House Office of Science and Technology Policy in the development of its unified and strengthened Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential <https://www.whitehouse.gov/ostp/news-updates/2024/05/06/united-states-government-policy-for-oversight-of-dual-use-research-of-concern-and-pathogens-with-enhanced-pandemic-potential/>.

 

This new U.S. government-wide policy, which combines the current dual use research of concern and enhanced potential pandemic pathogen oversight frameworks, expands the scope of research requiring additional scrutiny and strengthens our partnership with institutions to ensure robust review and oversight. NIH intends to work closely with the biomedical research community as we move towards the policy’s year effective date and encourages the biomedical research community to review the helpful and extensive guidance developed to assist with implementation.

 

NIH is encouraged that responsible science and vigorous oversight can evolve in tandem. This policy ushers in a new era of oversight that will support the nation’s ability to be prepared to counter biological threats, enhance pandemic preparedness, and achieve global health security.

 

Monica M. Bertagnolli, M.D.

Director, National Institutes of Health

 

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <www.nih.gov>.

 

NIH...Turning Discovery into Health -- Registered, U.S. Patent and Trademark Office

---

RELATED LINKS:

United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential

Statement on the Report of the National Science Advisory Board for Biosecurity <https://www.nih.gov/about-nih/who-we-are/nih-director/statements/statement-report-national-science-advisory-board-biosecurity>

 

###

 

This Statement is available online at:

<https://www.nih.gov/about-nih/who-we-are/nih-director/statements/statement-release-usg-policy-oversight-dual-use-research-concern-pathogens-enhanced-pandemic-potential>

To subscribe (or unsubscribe) from NIH News Release mailings, go to

<http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>.

If you subscribed via the NIH LISTSERV, go to <https://list.nih.gov/cgi-bin/wa.exe?A0=nihpress>.

 

 


[Index of Archives]     [CDC News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux